The lesson is clear: Not every cybersecurity snafu needs to be as bombastic as Merck’s “NotPetya” imbroglio. Behind the big headlines are much more common, albeit still risky, breaches—and the problem’s getting worse.
Of the 20 pharma companies Constella analyzed, five clocked more than 200,000 total data exposures and breaches, with some climbing as high as 400,000, Jonathan Nelson, digital intelligence specialist at Constella Intelligence, said in an interview.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,